Stay updated on Nivolumab and Urelumab in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed and older notices about funding lapse and a previous revision (v3.4.1) were removed; this is a minor maintenance update that does not affect the study details or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:58:04.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and site operations. Updated the page revision to v3.4.1 and removed the previous v3.4.0 revision.
    Difference
    0.4%
    Check dated 2026-02-04T10:28:11.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    These changes are minor UI/metadata updates (glossary toggle added, capitalization tweaks to labels like 'Last Update...' and 'No FEAR Act Data', and a revision note to v3.4.0) that do not affect core study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:23:49.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no study details, eligibility criteria, or outcomes appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:42:38.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The study locations were updated to include California, Colorado, Illinois, Maryland, and New York; the page revision was updated to v3.3.3; and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.7%
    Check dated 2025-12-23T21:27:44.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.3.2 added, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:39:19.000Z thumbnail image

Stay in the know with updates to Nivolumab and Urelumab in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.